Public Calendar: July 8- 14, 2018
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.
Official Name: Scott Gottlieb, M.D., Commissioner of Food and Drugs
Event Date: 07/10/2018
Location: Silver Spring, MD
Subject: Milk Labeling
FDA Participant/Group: Abram, Anna K; Boon, Caitlin S; Boon, Caitlin S; Ostroff, Stephen M; Smith, Candra A; Stearn, Douglas W;
Non FDA Participant/Group: Jeff Aiken (Tennessee Farm Bureau Federation); Justin Ferguson, Mike McCormick (Mississippi Farm Bureau Federation); Ron Gibson (Utah Farm Bureau Federation); Michael Nepveux (The American Farm Bureau Federation); Jim Holte (Wisconsin Farm Bureau Federation);
Event Date: 07/12/2018
Location: Silver Spring, MD
Subject: Food Products Derived from Animal Cell Culture
FDA Participant/Group: Several staff members from FDA
Non FDA Participant/Group: Industry, academia, government, media, and other registered participants
Official Name: Rachel Sherman, M.D., M.P.H., Principal Deputy Commissioner
No Significant Event
Official Name: Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis
No Significant Event
Official Name: Mark Abdoo , Acting Deputy Commissioner for Global Regulatory Operations and Policy
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Stephen M. Ostroff, M.D., Deputy Commissioner for Foods and Veterinary Medicine
No Significant Event
Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs
No Significant Event
Official Name: Jennifer Rodriguez, Acting Associate Commissioner for External Affairs
No Significant Event
Official Name: RADM Denise Hinton , Chief Scientist
No Significant Event
Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research
No Significant Event
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
Event Date: 07/10/2018
Location: Rockville, MD
Subject: Cell & Gene Therapy Products (CGTP) Symposium: Manufacturing, Quality, and Regulatory Considerations
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A
Event Date: 07/12/2018
Location: Washington, DC
Subject: American Society of Hematology Summit: Emerging Immunotherapies for Hematologic Diseases
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A
Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
Event Date: 07/11/2018
Location: Silver Spring, MD
Subject: Future Collaboration Opportunities
FDA Participant/Group: Yustein, Aron S; Margerrison, Edward; Gross, Thomas P;
Non FDA Participant/Group: Ronni Solomon, Marcus Schabacker, Michael Argentieri (Emergency Care Research Institute(ECRI));
Official Name: Susan T. Mayne Ph.D., Director, Center for Food Safety and Applied Nutrition
No Significant Event
Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name: Steven Solomon, Director, Center for Veterinary Medicine
No Significant Event
Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
No Significant Event
Official Name: Rebecca K. Wood, J.D., Chief Counsel
No Significant Event